Home LiteratureArticle Details
PMID: 3909150 Published · ppublish English Journal Article

Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

Vogel T, Weisgraber KH, Zeevi MI, Ben-Artzi H, Levanon AZ, Rall SC, Innerarity TL, Hui DY, Taylor JM, Kanner D

Abstract

Human apolipoprotein E (apoE) was produced in Escherichia coli by transforming cells with an expression vector containing a reconstructed apoE cDNA, a lambda PL promoter regulated by the thermolabile cI repressor, and a ribosomal binding site derived from the lambda cII or the E. coli beta-lactamase gene. Transformed cells induced at 42 degrees C for short periods of time (less than 20 min) produced apoE, which accumulated in the cells at levels of approximately equal to 1% of the total soluble cellular protein. Longer induction periods resulted in cell lysis and the proteolytic destruction of apoE. The bacterially produced apoE was purified by heparin-Sepharose affinity chromatography, Sephacryl S-300 gel filtration, and preparative Immobiline isoelectric focusing. The final yield was approximately equal to 20% of the initial apoE present in the cells. Except for an additional methionine at the amino terminus, the bacterially produced apoE was indistinguishable from authentic human plasma apoE as determined by NaDodSO4 and isoelectric focusing gel electrophoresis, amino acid composition of the total protein as well as its cyanogen bromide fragments, and partial amino acid sequence analysis (residues 1-17 and 109-164). Both the bacterially produced and authentic plasma apoE bound similarly to apolipoprotein B,E(low density lipoprotein) receptors of human fibroblasts and to hepatic apoE receptors. Intravenous injection resulted in similar rates of clearance for both the bacterially produced and authentic apoE from rabbit and rat plasma (approximately equal to 50% removed in 20 min). The ability to synthesize a bacterially produced human apolipoprotein with biological properties indistinguishable from those of the native protein will allow the production of large quantities of apoE for use in further investigations of the biological and physiological properties of this apolipoprotein.

MeSH Terms
Amino Acid Sequence Apolipoproteins E/genetics,metabolism Cloning, Molecular DNA/genetics Escherichia coli/genetics Genetic Vectors Humans Isoelectric Point Molecular Weight Plasmids Receptors, LDL/metabolism Recombinant Proteins/genetics,metabolism
Chemicals
Apolipoproteins E Receptors, LDL Recombinant Proteins DNA
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Vogel T
Weisgraber K H
Zeevi M I
Ben-Artzi H
Levanon A Z
Rall S C
Innerarity T L
Hui D Y
Taylor J M
Kanner D
References (38)
38 references, click to expand
  1. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.
    J Biol Chem. 1981 Sep 10;256(17):9077-83 PMID: 7263700
  2. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
    J Biol Chem. 1981 Jun 10;256(11):5646-55 PMID: 6263887
  3. Amino acid sequence of the signal peptide of OmpF, a major outer membrane protein of Escherichia coli.
    FEBS Lett. 1982 Jan 25;137(2):171-4 PMID: 7037455
  4. Human apolipoprotein E. The complete amino acid sequence.
    J Biol Chem. 1982 Apr 25;257(8):4171-8 PMID: 7068630
  5. Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
    Med Clin North Am. 1982 Mar;66(2):441-54 PMID: 7040846
  6. Regulation of the establishment of repressor synthesis in bacteriophage lambda.
    J Mol Biol. 1982 Feb 25;155(2):121-32 PMID: 6281444
  7. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.
    Hum Genet. 1982;60(4):344-51 PMID: 7106770
  8. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4696-700 PMID: 6289314
  9. Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes.
    Gene. 1982 Jun;18(3):199-209 PMID: 6751939
  10. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.
    J Lipid Res. 1982 Aug;23(6):911-4 PMID: 7130859
  11. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.
    J Clin Invest. 1983 Apr;71(4):1023-31 PMID: 6300187
  12. The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man.
    Hum Genet. 1982;62(3):233-6 PMID: 7169215
  13. Lipoprotein receptors and cholesterol homeostasis.
    Biochim Biophys Acta. 1983 May 24;737(2):197-222 PMID: 6303423
  14. Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans.
    Proc Natl Acad Sci U S A. 1983 Jun;80(12):3787-91 PMID: 6304737
  15. Apolipoprotein E polymorphism and coronary artery disease.
    Arteriosclerosis. 1983 Jul-Aug;3(4):310-5 PMID: 6882285
  16. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    J Biol Chem. 1983 Oct 25;258(20):12341-7 PMID: 6313652
  17. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
    J Biol Chem. 1983 Oct 25;258(20):12348-54 PMID: 6313653
  18. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Adv Intern Med. 1984;29:385-411 PMID: 6369930
  19. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E.
    J Biol Chem. 1984 May 10;259(9):5495-9 PMID: 6325438
  20. Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.
    J Biol Chem. 1984 May 25;259(10):6498-504 PMID: 6327682
  21. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
    J Biol Chem. 1984 Jun 10;259(11):7261-7 PMID: 6327714
  22. Plasma lipoproteins: apolipoprotein structure and function.
    J Lipid Res. 1984 Dec 1;25(12):1277-94 PMID: 6099394
  23. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene.
    J Biol Chem. 1985 May 25;260(10):6240-7 PMID: 3922972
  24. Nucleotide sequence and structure of the human apolipoprotein E gene.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3445-9 PMID: 2987927
  25. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Ann N Y Acad Sci. 1985;454:209-21 PMID: 3000263
  26. Preparative immobiline isoelectric focusing of plasma apolipoproteins on vertical slab gels.
    Anal Biochem. 1985 Dec;151(2):455-61 PMID: 4096384
  27. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    J Clin Invest. 1984 Apr;73(4):1024-33 PMID: 6323533
  28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  29. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.
    Biochemistry. 1978 Apr 18;17(8):1440-7 PMID: 206278
  30. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.
    J Biol Chem. 1979 May 25;254(10):4186-90 PMID: 220235
  31. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins.
    J Clin Invest. 1979 Sep;64(3):743-50 PMID: 224077
  32. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  33. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.
    J Lipid Res. 1980 Mar;21(3):316-25 PMID: 7381326
  34. Genetics of the apolipoprotein E system in man.
    Am J Hum Genet. 1980 May;32(3):339-47 PMID: 7386461
  35. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.
    J Clin Invest. 1980 Dec;66(6):1351-62 PMID: 7440719
  36. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.
    Biochemistry. 1981 Feb 17;20(4):1033-41 PMID: 6260135
  37. Expression of the Serratia marcescens lipoproteins gene in Escherichia coli.
    J Bacteriol. 1981 Jun;146(3):861-6 PMID: 7016834
  38. Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli.
    J Mol Biol. 1981 May 15;148(2):107-27 PMID: 7028991
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1985-12-00
Pages
8696-700
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC391503
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com